Market Overview:
The global oncology EMR software market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, growing demand for cloud-based oncology EMR software, and rising adoption of oncology EMR software by small and medium-sized hospitals. However, the high cost of oncology EMR software may restrain the growth of this market during the forecast period. On-premise based oncology EMR software held a major share in 2017 and is expected to continue its dominance during the forecast period. This can be attributed to its advantages such as improved security and control over data compared with cloud-based solutions.
Product Definition:
Oncology EMR software is a computer program used by oncologists to manage their patients' medical records. This software can include features such as patient tracking, treatment planning, and billing. Oncology EMR software can be very important for oncologists, as it can help them keep track of their patients' medical history and treatments.
On-premise:
On-premise software is a type of medical practice management software that is installed and used on the end user's computer. The information entered by the healthcare practitioners into the on-premise EMR software is then sent to the cloud, where it can be accessed by multiple doctors from different locations.
The growth factor for this market includes increasing adoption of cloud computing in healthcare industry, rising demand for remote patient monitoring & telehealth services.
Cloud Based:
Cloud-based software is a type of electronic medical record (EMR) that allows healthcare providers to store and access patient data from various sources such as imaging, lab tests, EHRs, etc. in a convenient manner. Cloud-based software has been gaining popularity due to its cost effectiveness and ease of use.
Application Insights:
The chemotherapy oncology segment dominated the global oncology EMR software market in 2017. This can be attributed to factors such as increasing adoption of these applications for managing clinical trials and an increase in number of cancer patients undergoing chemotherapy. Moreover, a rise in R&D activities pertaining to the development of novel drugs is expected to boost demand over the forecast period.
Radiation oncology is anticipated to witness significant growth over the forecast period owing to a rise in demand for radiation therapy equipment and devices across hospitals and clinics, coupled with government initiatives promoting its use worldwide.
Regional Analysis:
North America dominated the global oncology EMR software market in 2017. This can be attributed to presence of key players such as Allscripts Healthcare Solutions, Inc.; GE Healthcare; and Siemens Healthineers AG in this region. Moreover, increasing adoption of healthcare IT systems by hospitals and rising demand for efficient cancer treatment procedures are some other factors driving the growth of this regional market.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing government initiatives for improving healthcare infrastructure coupled with growing awareness about advanced technologies among end-users such as physicians and medical professionals. Furthermore, economic development coupled with improvement in healthcare infrastructure is also anticipated to drive growth during the forecast period.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is one of the key growth drivers for the oncology EMR software market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and around 600,920 people will die from this disease. This growing prevalence of cancer is expected to drive demand for oncology EMR software solutions over the forecast period.
- Rising awareness about early diagnosis and treatment: There is an increasing awareness among people about early diagnosis and treatment options for various types of cancers which is propelling demand for oncology EMR software solutions across the globe. In addition, governments are also investing heavily in initiatives to raise awareness about cancer and its prevention methods which is further aiding market growth prospects over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Oncology EMR Software Market Research Report
By Type
On-premise, Cloud Based
By Application
Chemotherapy Oncology, Radiation Oncology
By Companies
Kareo, AdvancedMD, DrChrono, Greenway Health, CompuGroup Medical, Advanced Data Systems, CrisSoft, Waystar, Shavara
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Oncology EMR Software Market Report Segments:
The global Oncology EMR Software market is segmented on the basis of:
Types
On-premise, Cloud Based
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chemotherapy Oncology, Radiation Oncology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kareo
- AdvancedMD
- DrChrono
- Greenway Health
- CompuGroup Medical
- Advanced Data Systems
- CrisSoft
- Waystar
- Shavara
Highlights of The Oncology EMR Software Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- On-premise
- Cloud Based
- By Application:
- Chemotherapy Oncology
- Radiation Oncology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oncology EMR Software Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oncology EMR software is a type of electronic medical record (EMR) system used in the healthcare industry to manage patient information. Oncology EMR software can be used to track patients' medical history, medications, and other health data. This information can help doctors diagnose and treat cancer patients more effectively.
Some of the key players operating in the oncology emr software market are Kareo, AdvancedMD, DrChrono, Greenway Health, CompuGroup Medical, Advanced Data Systems, CrisSoft, Waystar, Shavara.
The oncology emr software market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oncology EMR Software Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oncology EMR Software Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oncology EMR Software Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oncology EMR Software Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oncology EMR Software Market Size & Forecast, 2018-2028
4.5.1 Oncology EMR Software Market Size and Y-o-Y Growth
4.5.2 Oncology EMR Software Market Absolute $ Opportunity
Chapter 5 Global Oncology EMR Software Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oncology EMR Software Market Size Forecast by Type
5.2.1 On-premise
5.2.2 Cloud Based
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oncology EMR Software Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oncology EMR Software Market Size Forecast by Applications
6.2.1 Chemotherapy Oncology
6.2.2 Radiation Oncology
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oncology EMR Software Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oncology EMR Software Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oncology EMR Software Analysis and Forecast
9.1 Introduction
9.2 North America Oncology EMR Software Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oncology EMR Software Market Size Forecast by Type
9.6.1 On-premise
9.6.2 Cloud Based
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oncology EMR Software Market Size Forecast by Applications
9.10.1 Chemotherapy Oncology
9.10.2 Radiation Oncology
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oncology EMR Software Analysis and Forecast
10.1 Introduction
10.2 Europe Oncology EMR Software Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oncology EMR Software Market Size Forecast by Type
10.6.1 On-premise
10.6.2 Cloud Based
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oncology EMR Software Market Size Forecast by Applications
10.10.1 Chemotherapy Oncology
10.10.2 Radiation Oncology
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oncology EMR Software Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oncology EMR Software Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oncology EMR Software Market Size Forecast by Type
11.6.1 On-premise
11.6.2 Cloud Based
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oncology EMR Software Market Size Forecast by Applications
11.10.1 Chemotherapy Oncology
11.10.2 Radiation Oncology
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oncology EMR Software Analysis and Forecast
12.1 Introduction
12.2 Latin America Oncology EMR Software Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oncology EMR Software Market Size Forecast by Type
12.6.1 On-premise
12.6.2 Cloud Based
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oncology EMR Software Market Size Forecast by Applications
12.10.1 Chemotherapy Oncology
12.10.2 Radiation Oncology
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oncology EMR Software Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oncology EMR Software Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oncology EMR Software Market Size Forecast by Type
13.6.1 On-premise
13.6.2 Cloud Based
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oncology EMR Software Market Size Forecast by Applications
13.10.1 Chemotherapy Oncology
13.10.2 Radiation Oncology
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oncology EMR Software Market: Competitive Dashboard
14.2 Global Oncology EMR Software Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Kareo
14.3.2 AdvancedMD
14.3.3 DrChrono
14.3.4 Greenway Health
14.3.5 CompuGroup Medical
14.3.6 Advanced Data Systems
14.3.7 CrisSoft
14.3.8 Waystar
14.3.9 Shavara
